Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alexis R. Schiazza"'
Publikováno v:
Physiological Reports, Vol 9, Iss 23, Pp n/a-n/a (2021)
Abstract Renal olfactory receptor 1393 (Olfr1393) is an understudied sensory receptor that contributes to glucose handling in the proximal tubule. Our previous studies have indicated that this receptor may serve as a regulator of the sodium glucose c
Externí odkaz:
https://doaj.org/article/276e04cce46d41ba8b39498324e0108b
Autor:
Peter J. Altshuler, Jason J. Han, Amit Iyengar, Alexis R. Schiazza, Mark R. Helmers, Pavan Atluri, D. Alan Herbst, Robin Hu
Publikováno v:
Journal of Cardiac Failure. 28:32-41
Background Because of ongoing shortages of donors for heart transplantation, the use of donor candidates whose availabilities are the result of drug overdoses (ODs) has become increasingly prevalent, even though these donors carry a high preponderanc
Autor:
Mark R. Helmers, Zhiliang J Cheng, Alexis R. Schiazza, Jennifer J. Chung, Peter J. Altshuler, Tsourkas Andrew, Samuel Kim, Jakub Jarmula, Robin Hu, Pavan Atluri
Publikováno v:
Circulation. 142
Introduction: Revascularization relieves myocardial ischemia but induces additional reperfusion injury by oxidative stress. Superoxide dismutase (SOD) is a potent antioxidant with preclinical promise in reducing reperfusion injury but is not well ret
Autor:
Jason A. Burdick, Peter J. Altshuler, Jakub Jarmula, Alexis R. Schiazza, Samuel Kim, Mark R. Helmers, Pavan Atluri
Publikováno v:
Circulation. 142
Introduction: Mesenchymal Stem Cell (MSC)-derived Extracellular Vesicles (EVs) are an emerging regenerative therapy for treatment of ischemic cardiomyopathy. In this study, we determine the efficacy of MSC-EV therapy in a shear-thinning hydrogel (STG
Autor:
Alexis R. Schiazza, Blythe D. Shepard
Publikováno v:
The FASEB Journal. 33
Autor:
Amit Iyengar, Alexis R. Schiazza, Mark R. Helmers, Peter J. Altshuler, Robin Hu, Jason J. Han, D. Herbst, P. Alturi
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S129
Purpose Rates of simultaneous heart kidney (SHK) transplant are increasing annually. SHK confers survival benefit in recipients with pre-transplant renal failure, but its role in renal failure patients bridged to transplant with continuous-flow ventr
Publikováno v:
The FASEB Journal. 34:1-1